Association of Receipt of the Fourth BNT162b2 Dose With Omicron Infection and COVID-19 Hospitalizations Among Residents of Long-term Care Facilities.

ABSTRACT:

Importance

The administration of a fourth BNT162b2 COVID-19 vaccine dose was approved in Israel in December 2021 for individuals 60 years or older who were vaccinated with a third dose 4 months previously or earlier to control the substantial surge of the SARS-CoV-2 Omicron variant. Nonetheless, the association between receipt of the fourth dose and protection against infection remains elusive.

Objective

To determine the association of the fourth BNT162b2 dose with protection against SARS-CoV-2-related infections, hospitalizations, and deaths during the Omicron surge in long-term care facility (LTCF) residents.

Design, setting, and participants

This prospective cohort study was conducted in Israel between January 10 and March 31, 2022 and included LTCF residents 60 ye

SUBMITTER: Muhsen K 

PROVIDER: S-EPMC9227688 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature